Labcorp Holdings Inc. Q4 2025 Earnings Call Summary

Moby Strategic Performance Drivers and Operational Context. Performance in 2025 was driven by a 7% top-line increase and 13% ...

Labcorp Holdings Inc. (LH) Q4 2025 Earnings Call Transcript

Labcorp Holdings Inc. ( LH) Q4 2025 Earnings Call February 17, 2026 9:00 AM EST Good day, and thank you for standing by. Welcome to the Q4 2025 Labcorp Holdings Earnings Conference Call. [Operator ...

Labcorp Holdings Inc. (NYSE:LH) Q4 2025 earnings call transcript

Labcorp Holdings Inc. (NYSE:LH) Q4 2025 Earnings Call Transcript February 17, 2026 Labcorp Holdings Inc. misses on earnings expectations. Reported EPS is $1.98 EPS, expectations were $3.95. Operator: ...

LH Q4 Deep Dive: Specialty Testing and Hospital Partnerships Offset Volume Challenges

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 5.6% year on year to $3.52 billion. On the other hand, the company’s ...

Labcorp outlines 5.4% midpoint revenue growth and 9% EPS target for 2026 while advancing specialty and AI initiatives

Guidance for 2026 is for 5.4% midpoint revenue growth and 9% adjusted EPS growth, compared to 2025's 7% revenue and 13% EPS growth. Margin expansion continues, but with slightly moderated growth rates ...

Labcorp Announces 2025 Fourth Quarter and Full Year Results

Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced results for the fourth quarter and full year ended December 31, 2025, and ...